U.S., Feb. 18 -- An application to own the trademark for 'VEPJUZYRN' has been filed on Dec. 10, 2025.
Owner(s):
Eli Lilly and Company; Lilly Corporate Center, , INDIANA
Goods and/or Services:
For: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches,...